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ABSTRACT: The propensity to misfold and self-assemble into
stable aggregates is increasingly being recognized as a common
feature of protein molecules. Our understanding of this
phenomenon and of its links with human disease has improved
substantially over the past two decades. Studies thus far, however,
have been almost exclusively focused on cytosolic proteins,
resulting in a lack of detailed information about the misfolding
and aggregation of membrane proteins. As a consequence, although
such proteins make up approximately 30% of the human proteome
and have high propensities to aggregate, relatively little is known
about the biophysical nature of their assemblies. To shed light on this issue, we have studied as a model system an archetypical
representative of the ubiquitous major facilitator superfamily, the Escherichia coli lactose permease (LacY). By using a
combination of established indicators of cross-β structure and morphology, including the amyloid diagnostic dye thioﬂavin-T,
circular dichroism spectroscopy, Fourier transform infrared spectroscopy, X-ray ﬁber diﬀraction, and transmission electron
microscopy, we show that LacY can form amyloid-like ﬁbrils under destabilizing conditions. These results indicate that
transmembrane α-helical proteins, similarly to cytosolic proteins, have the ability to adopt this generic state.
A wide range of medical conditions, including neuro-degenerative disorders such as Alzheimer’s and Parkin-
son’s diseases, are associated with the misfolding and
aggregation of speciﬁc proteins into amyloid ﬁbrils.1−4 In vivo
and in vitro studies of these disease-related aggregates have led
to the recognition of their common structural features, despite
the diversity of the amino acid sequences and native state
structures of the proteins by which they are formed.4 In
particular, it has been shown that amyloid ﬁbrils possess a
cross-β architecture, in which the β-strands that make up the β-
sheets are perpendicular to the ﬁbril axis.2,4,5 As this ﬁbrillar
architecture can be adopted by a wide variety of diﬀerent
proteins,6−9 it has been suggested that polypeptide chains have
a generic ability to form amyloid ﬁbrils.4,10
Despite a growing body of evidence of the widespread nature
of the amyloid phenomenon,3,4,6 little evidence has been
obtained about this type of behavior in the case of membrane
proteins. This absence of information is particularly remarkable,
as it is well-known that the highly hydrophobic nature of
membrane proteins makes them prone to self-association and
aggregation under many conditions.11 Indeed, hundreds of
membrane proteins have been observed to aggregate upon
aging in Caenorhabditis elegans,12 and a set of genes found to be
associated with human neurodegenerative disorders has been
linked with membrane proteins involved in the oxidative
phosphorylation pathway.13 In addition, predictive models of
protein homeostasis indicate that the aggregation propensity of
membrane proteins is very high.14 Moreover, the amyloid-β
peptide (Aβ), which is associated with Alzheimer’s disease, is a
proteolytic fragment of the membrane protein APP,15 and the
aggregation and formation of ﬁbrils by fragments of luminal
membrane protein domains have been reported.16
Several reasons lie behind the current lack of detailed
structural information about membrane protein aggregation,
many of which are related to the challenges inherent in their
recombinant production and puriﬁcation. These steps remain
among the major bottlenecks in many structural and functional
analyses of these important biological components.17 In
contrast to the situation for cytosolic proteins, membrane
proteins often require expression and puriﬁcation procedures to
be performed in lipid or detergent environments.18 Despite
these diﬃculties, a more detailed knowledge of this group of
proteins is absolutely essential for the understanding of normal
and aberrant biological processes, as they represent ∼30% of
the human proteome19 and comprise a substantial fraction of
currently known drug targets.20
Moreover, an increased level of β-sheet structure has sparsely
been reported for disease-related membrane proteins. Perhaps
the best studied of these proteins is cystic ﬁbrosis trans-
membrane conductance regulator (CFTR), an ABC transporter
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containing 12 transmembrane helices. Several mutations of this
membrane protein result in a variety of cystic ﬁbrosis
phenotypes,21 spanning defects in synthesis, processing,
traﬃcking, and functional deﬁcits. Although most studies
report a fast degradation of dysfunctional CFTR rather than
formation of deposits,22 it has been indicated that misfolded
aggregates with highly organized arrays of β-strands can form
for the P205 variant.23 Retinitis pigmentosa, a progressive
retinal degenerative disease, has been shown to be associated
with mutations in rhodopsin, an α-helical membrane protein of
the G-coupled protein receptor (GCPR) family.24 Indeed,
because a majority of these mutations result in the incorrect
folding of the apoprotein opsin, retinitis pigmentosa has been
classiﬁed as a protein misfolding disease.25,26 Despite the fact
that misfolded opsin was initially presumed to form disordered
aggregates in the endoplasmic reticulum (ER),27 it has recently
been shown that aggregates of the opsin variants G188R and
P23H, formed in HEK293 cells, exhibit a high β-structure
content.28 These aggregates appear to be distinct from amyloid
ﬁbrils because they do not enhance the ﬂuorescence of
thioﬂavin-T (ThT).28 A stronger tendency to form ordered
β-sheet structure has also been reported for a model peptide
with the partial sequence of a transmembrane domain of
peripheral myelin protein 22 (PMP22).29 PMP22 is an α-helical
transmembrane glycoprotein primarily expressed in Schwann
cells, and its mutations are known to cause the peripheral
neuropathy Charcot-Marie-Tooth disease.30 Aggresome for-
mation by this protein has been reported upon its over-
expression in mice, although the structure of the protein within
these aggregate-rich inclusions is not yet clear.31 In addition,
there is recent evidence of the formation of ThT-positive
aggregates of the β-barrel transmembrane domain of outer
membrane protein A (OmpA) formed in the absence of lipid or
lipid-mimetic membranes and in the presence of high
concentrations of urea.32
Overall, although increases in the level of β-sheet structure
have been reported in a number of cases,23,28,31,32 it remains
unclear whether membrane proteins have an inherent
propensity to convert into amyloid ﬁbrils similar to that of
cytosolic proteins. To address this problem, we have studied
LacY, a representative of the major facilitator superfamily of
transporters that are prevalent across prokaryotes and
eukaryotes. This 417-residue protein is composed of 12
transmembrane α-helices arranged in two domains, with a
substrate binding site at the domain interface.33 Its crystal
structure has been determined to 3.6 Å resolution,34 and its
function has been studied in great detail.35 The structure and in
vitro folding of LacY have been studied within both micelles
and liposomes.36−38 These simple lipid-mimetic systems
represent an ideal starting point for biophysical studies, and
the relevance of their use is supported by extensive studies
showing the tolerance of membrane proteins to changing lipid
environments.39
We should mention that, in vivo, LacY is translated directly
into lipid membranes in Escherichia coli, in the same way that
most membrane proteins are directly translated into the ER
membrane where they then reside.40 Furthermore, a network of
quality-control mechanisms has co-evolved with the biosyn-
thesis and traﬃcking of membrane proteins in the ER, with the
speciﬁc purpose of preventing their aggregation.41 By contrast,
in our in vitro study, we observe aggregation reactions in a
convenient detergent system. Although these conditions are
nonphysiological, and our in vitro assays also lack the protein
homeostasis controls present in the cellular environment, they
allow us to explore the range of structural states accessible to
LacY. Consistently, a number of experimental studies have
already provided evidence of membrane protein aggregation
within the cellular environment. For example, even if in many
proteomics protocols membrane proteins tend to be discarded
prior to analysis,42 several studies have reported the presence of
membrane proteins in aggregates found in disease tissues. In
particular, lysosomal ATPase and mitochondrial ATPase
components have been found to co-aggregate in post-mortem
amyloid plaques43 and neuroﬁbrillary tangles,44 respectively,
and the accumulation of the Parkin-associated transmembrane
receptor Pael-R in Lewy bodies has been reported.45 These
examples indicate that membrane proteins under stress can
aggregate in vivo outside their native environments.
We report here the conversion of LacY into ﬁbrillar
aggregates with the characteristic features of cross-β structure
and therefore demonstrate that an α-helical membrane protein
can adopt a stable amyloid-like state analogous to those
observed for cytosolic proteins.
■ MATERIALS AND METHODS
Generation of the Aggregation Propensity Proﬁle of
LacY. The CamSol method46 was used to calculate the
sequence-dependent intrinsic solubility of LacY, which we
adopted as an indicator of its aggregation propensity, as both
solubility and aggregation propensity describe the tendency of
proteins to convert from the native state to insoluble
aggregates. The CamSol method was derived by considering
the physicochemical properties of the amino acid sequences
that are most responsible for their aggregation behavior,
including in particular the hydrophobic patterns, which tend to
drive the aggregation process, and the presence of “gatekeeper”
residues (charged residues and prolines), which tend to prevent
it.46 The indication of α-helices and coil in the ﬁgure was based
on the native structure of LacY.34,47
LacY Expression and Puriﬁcation. LacY was puriﬁed as
previously described37 with modiﬁcations. LacY was expressed
in One Shot BL21-AI chemically competent E. coli (Thermo
Fisher Scientiﬁc, Paisley, U.K.), using the kanamycin resistant
plasmid pET-28a. The cultures were grown at 37 °C in LB
medium and induced with 0.1% arabinose and 1 mM isopropyl
β-D-1-thiogalactopyranoside at an OD600 of 0.7−0.8 AU, and
the cells were harvested by centrifugation (5000g for 45 min).
Following growth and induction, the cells were lysed by three
cycles in a high-pressure homogenizer, and the membranes
were sedimented by centrifugation (100000g for 4 °C at 30
min) (ultracentrifuge, rotor 70Ti, Beckman Coulter, High
Wycombe, U.K.). The pellets were resuspended and incubated
(4 °C for 2 h) in 25 mL of solubilization buﬀer [200 mM NaCl,
20 mM imidazole, 10 mM β-mercaptoethanol, 40 mM DDM,
and an EDTA free protease inhibitor cocktail tablet (Roche
Diagnostics Ltd., Burgess Hill, U.K.)]. The solubilized
membranes were centrifuged (100000g and 4 °C for 30 min),
and the supernatant was retained for puriﬁcation. For all steps
of puriﬁcation, the buﬀer contained 50 mM sodium phosphate
(pH 7.4), 10% (v/v) glycerol, 10 mM β-mercaptoethanol, and
1 mM DDM, with additional components indicated in brackets.
Initial puriﬁcation was performed with a 1 mL HisTrap HP
Ni2+ aﬃnity column (GE Healthcare Ltd., Little Chalfont,
U.K.), previously equilibrated with 10 column volumes (CV) of
puriﬁcation buﬀer (20 mM imidazole). Following loading of the
sample, the column was washed with 50 CV of puriﬁcation
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buﬀer (20 mM imidazole) and LacY was eluted with 5 CV of
elution buﬀer (75 mM imidazole). The eluted protein was
transferred directly to a gel ﬁltration column (SUP200
Superdex, GE Healthcare) to remove imidazole as well as
multimeric protein species. The resulting protein fractions were
analyzed by sodium dodecyl sulfate−polyacrylamide gel
electrophoresis (SDS−PAGE) using NuPAGE 4 to 12% gels
with MES buﬀer (Thermo Fisher Scientiﬁc) and UV−vis
spectroscopy to verify the purity of the protein samples and
determine their concentrations, respectively. The LacY
concentration in the supernatant was determined from the
absorbance at 280 nm, using an εLacY of 76391 M
−1 cm−1. After
puriﬁcation, aliquoted samples were frozen in liquid N2 and
stored at −80 °C until they were used.
LacY Aggregation Procedure. LacY in 50 mM sodium
phosphate and 0.05% DDM (pH 7.4) was used directly as
obtained from the puriﬁcation (2 μM, 4 μM, and occasionally 8
μM samples) or concentrated (to 8, 16, or 32 μM), and
aggregation was initiated by increasing the temperature of the
sample to 37 °C. When concentration of the protein was
required, Vivaspin20 concentrators with a 100 kDa cutoﬀ
(Millipore, Watford, U.K.) were used as these devices were
reported to cause insigniﬁcant changes in the DDM
concentration.48,49 The ﬁnal DDM concentration was deter-
mined via colorimetric determination of the glycoside
content.49 The samples were continuously kept on ice or at 4
°C to minimize aggregate formation prior to any measurement.
Concentrating the samples took approximately 35 min from
defrosting. Samples were used immediately after being
concentrated and were not refrozen.
ThT Fluorescence Assay. LacY (2, 4, and 8 μM as
obtained after puriﬁcation) in 50 mM sodium phosphate and
0.05% DDM (pH 7.4) was incubated at 37 °C in the presence
of 4 μM ultrapure ThT (Sigma-Aldrich, Dorset, U.K.). The
change in the ThT ﬂuorescence intensity (excitation at 440 nm,
emission at 480 nm) was monitored over 48 h using a
FLUOstar Optima plate reader (BMG Labtech, Aylesbury,
U.K.) under quiescent conditions. Corning 96-well plates with
half-area (black/clear bottom polystyrene) nonbinding surfaces
(Fisher Scientiﬁc, Loughborough, U.K.) were used.
Analysis of LacY in the Supernatant. At the end of an
aggregation experiment, the samples were centrifuged (15000g
for 15 min), and the concentration of the free monomer was
calculated by measuring the UV−vis spectrum of the
supernatant. The same samples were analyzed via SDS−
PAGE. An aliquot of the LacY supernatant solution (15 μL)
was mixed with NuPAGE LDS sample buﬀer (ThermoFisher
Scientiﬁc), and 10 μL of the solution was run on a NuPAGE 4
to 12% Bis-Tris gel (ThermoFisher Scientiﬁc). A tricolor
protein marker (Stratech Scientiﬁc, Suﬀolk, U.K.) was run on
the same gel. The gel was stained with InstantBlue (Expedeon,
Swavesey, U.K.).
Circular Dichroism Spectroscopy. A LacY solution (2
μM) in 50 mM phosphate buﬀer and 0.05% DDM (pH 7.4),
before and after incubation at 37 °C for 48 h, was deposited in
a circular cell. Far-UV CD spectra were recorded on a model
410 Aviv circular dichroism spectrophotometer (Biomedical
Figure 1. CamSol proﬁle of LacY, as an indicator of its aggregation propensity. (A) Native structure of LacY (front and bottom view), which is
shown for reference. The Protein Data Bank structure 2V8N34 was used to draw the cartoons, with cylinders representing α-helices and ribbons
representing disordered coils. (B) CamSol46 proﬁle of LacY (see Materials and Methods). Regions colored red have a low intrinsic solubility and
hence a high aggregation propensity. The positions of α-helices (as derived from ref 47) are indicated by horizontal gray bars.
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Inc., Lakewood, NJ), with specially adapted sample detection
(the detector is placed closer to the sample) to minimize
scattering artifacts. Quartz circular cells were used, and CD
spectra were obtained by averaging two to ﬁve individual
spectra recorded between 260 and 190 nm at a 0.5 nm interval
with an averaging time of 2 s. For each protein sample, the CD
signal of the buﬀer without protein was recorded and
subtracted from the CD signal of each protein sample. The
multiple scans were averaged, and the buﬀer background was
subtracted. The data were then converted from millidegrees to
mean residue ellipticity.50
Fourier Transform Infrared Spectroscopy. A LacY
solution (concentrated to 16 μM) in 50 mM phosphate buﬀer
and 0.05% DDM (pH 7.4), before and after incubation at 37
°C for 48 h, was deposited (10 μL) into a BioATR cell (Bruker
Optics, Coventry, U.K.). Fourier transform infrared (FT-IR)
absorption spectra were collected in absorbance mode on an
FT-IR Vertex 70 (Bruker) spectrometer ﬁtted with a BioATR
cell (Bruker Optics, Coventry, U.K.). Spectra were corrected
for the presence of 50 mM sodium phosphate (pH 7.4) and
0.05% DDM. The secondary derivative for each spectrum was
calculated using OriginPRO. To reduce the noise, a FFT ﬁlter
(10 pt) was initially applied; the curves were successively
normalized and smoothed by a Savitski−Golay ﬁlter (9 points).
Transmission Electron Microscopy. LacY solutions
(concentrated to 16 μM) in 50 mM phosphate buﬀer and
0.05% DDM (pH 7.4) were incubated at 37 °C for 48 h, and 5
μL of the sample was applied to carbon-coated 400 mesh
copper grids (EM Resolutions, Saﬀron Walden, U.K.). Samples
were stained with 2% (w/v) uranyl acetate and imaged using a
FEI Tecnai G2 transmission electron microscope (Cambridge
Advanced Imaging Centre (CAIC), University of Cambridge).
Images were analyzed using the SIS Megaview II Image
Capture system (Olympus).
X-ray Fiber Diﬀraction Pattern Analysis. LacY solutions
(concentrated to 16 and 32 μM) in 50 mM phosphate buﬀer
and 0.05% DDM (pH 7.4) were incubated at 37 °C for 48 h.
The samples for ﬁber diﬀraction were dialyzed against 50 mM
sodium phosphate (pH 7.4) and 0.05% DDM, and a 5 μL
aliquot was pipetted between wax stalks and left to dry. The
experiments were performed at the Crystallographic X-ray
Facility of the Department of Biochemistry of the University of
Cambridge. X-rays with a wavelength of 1.5418 Å were
produced by a rotating copper anode MISCROSTAR generator
(Bruker-AXS, Ltd.), collimated, and focused by HELIOS-MX
high-brightness multilayer X-ray optics. Images were acquired
on a PLATINUM135 CCD area detector (Bruker-AXS, Ltd.,
Rigaku-MSC). The exposure time for the diﬀraction images was
60 s in each case. Viewing and analysis of the diﬀraction pattern
were performed using the PORTEUM2 software package
(PROTEUM 2 User Manual, Bruker AXS, 2010).
■ RESULTS AND DISCUSSION
LacY Has a Strong Intrinsic Propensity to Aggregate.
In a preliminary assessment, we used the CamSol method46 to
calculate the sequence-dependent solubility of LacY (Figure 1),
which is inversely related to the aggregation propensity score
(see Materials and Methods). As the native state of LacY
comprises 12 transmembrane α-helices, the sequence may be
expected to include highly hydrophobic and aggregation-prone
regions outside its natural lipid environment, which are indeed
present (red regions in the sequence proﬁle in Figure 1).
LacY Readily Forms Aggregates at 37 °C and pH 7.4.
LacY was expressed and puriﬁed into n-dodecyl β-D-maltoside
(DDM) micelles according to standard procedures.37 The
detergent was used at a concentration of 1 mM (or 0.05%) in
all experiments, which is well above its critical micelle
concentration (CMC) of 0.16 mM.51 Long chain maltoside
detergents are generally used for LacY puriﬁcation as they are
well-known to eﬀectively maintain the protein in solution.52 In
addition, it was established that LacY is stabilized by low
temperature and glycerol,52 which was added in all puriﬁcation
buﬀers (Materials and Methods). Despite these considerations,
puriﬁcation of LacY is challenging as the protein tends to
aggregate readily at room temperature and even when kept on
ice for a few hours. Furthermore, as several biophysical
techniques utilized in our studies require protein concen-
trations (in the range of at least 15−30 μM) higher than those
initially obtained from the puriﬁcation (typically in the range of
2−6 μM), the samples often required concentrating, thereby
placing the protein under conditions where it is particularly
vulnerable to aggregation prior to the start of any experiment.
This aspect of the system made it diﬃcult to characterize the
precise starting point of the aggregation reaction and to avoid
consistently the presence of a small fraction of aggregated
species at the initiation of the experiments.
In the experimental protocol described here, LacY [in 50
mM sodium phosphate (pH 7.4) and 0.05% DDM] was used as
obtained from the puriﬁcation procedure (2, 4, and 8 μM
samples) or concentrated to 8, 16, or 32 μM. Amyloid-like
structures often are observed under conditions that destabilize
the protein under study,7 and as an increase in temperature in
particular is known to destabilize LacY,52 aggregation of the
protein was initiated by increasing the temperature of the
sample from 4 to 37 °C. Visible precipitation of LacY in the
micellar environment was observed after approximately 4 h for
the 16 μM samples to approximately 8 h for the 2 μM samples,
with increasing turbidity of the solutions at longer incubation
times of ≤48 h. Aliquots taken at diﬀerent time points during
the incubation were centrifuged, and the supernatant at each
time point was analyzed. The concentration of LacY in the
supernatant at each time point was obtained from UV−vis
spectra at 280 nm (Table 1) and observed to decrease gradually
over time, resulting in <20% of the initial protein remaining in
solution after incubation for 48 h. This ratio is consistent for
the samples at higher concentrations. The same samples were
Table 1. LacY Concentrations in the Supernatant over
Timea
time (h) A280 c (μM)
0 0.148 1.94
2 0.128 1.68
4 0.089 1.15
6 0.085 1.11
24 0.052 0.68
48 0.031 0.40
aLacY solutions (2 μM) incubated in 50 mM phosphate buﬀer (pH
7.4) with 0.05% DDM (37 °C for 48 h) were centrifuged after 0, 2, 4,
6, 24, and 48 h to precipitate the aggregated fraction, and the UV−vis
signal at 280 nm of the remaining supernatant was monitored. The
LacY concentration in the supernatant was determined from the
absorbance at 280 nm, using an εLacY of 76391 M
−1 cm−1. An average
of two measurements from separate samples is shown (standard
deviation ± 0.005 for A280).
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analyzed by SDS−PAGE (Figure 2), and the increasingly faint
bands observed for the samples after increasing incubation
times conﬁrm the nearly complete conversion of the monomer
into precipitating species after 48 h.
In the following sections, we describe a range of biophysical
techniques that we have used to deﬁne the structural nature of
the observed aggregates and to characterize their properties.
Because nearly complete precipitation of LacY from solution
was observed after 48 h, we did not extend experiments beyond
this initial time frame.
LacY Aggregates Are ThT-Positive. Amyloid-speciﬁc
ﬂuorescent dyes have been used for many years to identify
amyloid assemblies,1 and in vitro assays involving these
compounds remain a powerful approach to characterizing
amyloid-like ﬁbrils and to monitoring the kinetics of their
formation. One of the most widely used dyes is ThT, a
positively charged benzothiazole salt that shows increased
ﬂuorescence upon interaction with amyloid ﬁbrils.53 Membrane
proteins are highly hydrophobic in nature and could therefore
adopt a mode of binding to ThT diﬀerent from that of cytosolic
proteins. Although some studies have suggested that binding of
ThT to amyloid ﬁbrils involves the formation of ThT micelles
as a result of hydrophobic interactions,54 a model in which ThT
speciﬁcally interacts with the cross-β strands that characterize
the unique amyloid architecture is more widely accepted.53
LacY solutions at concentrations of 2, 4, and 8 μM were
incubated at 37 °C in the presence of 4 μM ThT, and the
ﬂuorescence signal was monitored over the course of 48 h.
Within minutes, an increase in the ﬂuorescence intensity at 480
nm was observed, and sigmoidal aggregation curves were
obtained by plotting the relative ﬂuorescence intensities as a
function of time (Figure 3). The initial high intensities, which
were seen in all samples, are often observed in this type of
kinetic experiment and can be attributed to an equilibration at
the higher temperature (from 4 to 37 °C in this case).
Normalization of the data shows an increase in the aggregation
rate with an increasing initial protein concentration (≤8 μM, as
these samples could be obtained directly after puriﬁcation
without the need for concentration) (Figure 3B). The ThT-
positive character of the LacY aggregates provides a ﬁrst
indication that they may have a β-sheet-rich amyloid-like
nature. The enhanced ﬂuorescence of ThT inside micelles,
however, could be a result of electrostatic interactions with the
charged detergent molecules.55 Indeed, signiﬁcant eﬀects of this
type have been observed for ThT simply in the presence of the
anionic surfactant sodium dodecyl sulfate (SDS), whereas
relatively insigniﬁcant intensity changes were observed with
neutral detergents such as Tween 20 and Triton X-100.55
Because DDM belongs to the latter category of detergents, only
minor intensity changes were expected, and none were
observed, in its presence (Figure S1). All spectra were corrected
for potential buﬀer eﬀects by monitoring the ThT ﬂuorescence
in sodium phosphate buﬀer containing DDM concentrations
equal to those of the sample under investigation, showing that
the increase in ThT ﬂuorescence correlates with the presence of
LacY aggregates as determined by centrifugation.
LacY Is Converted from α-Helical to Parallel β-Sheet
Structure. In addition to monitoring dye binding properties,
direct detection of their characteristic β-sheet architecture is a
key parameter in the identiﬁcation of amyloid-like ﬁbrils.
Circular dichroism (CD) and FT-IR spectroscopies are
powerful techniques used to characterize protein secondary
structure content and were used to monitor the changes in the
LacY secondary structure upon aggregation.56 The native LacY
monomer has been studied extensively; an α-helical structure
Figure 2. Fraction of LacY in the supernatant over time. LacY
solutions (2 μM) incubated in 50 mM phosphate buﬀer (pH 7.4) with
0.05% DDM (37 °C for 48 h) were centrifuged to precipitate the
aggregated fraction, and the remaining supernatant was analyzed by
SDS−PAGE after 0, 1, 2, 3, 4, 5, 6, 7, 8, 24, and 48 h (as indicated).
LacY appears at ∼28 kDa because it does not unfold in SDS and thus
runs in its folded state (its expected MW is 48 kDa). The experiment
was repeated twice; a representative data set is shown.
Figure 3. Enhancement of ThT ﬂuorescence by LacY aggregates. (A) ThT ﬂuorescence changes in monomer solutions of 2 μM (yellow), 4 μM
(red), and 8 μM (blue) LacY (in duplicate) in 50 mM sodium phosphate (pH 7.4) with 0.05% DDM. The solutions were incubated (37 °C for 48 h)
in the presence of 4 μM ThT, and the ThT ﬂuorescence was continuously monitored. The ﬂuorescence spectra were corrected for the signal in 50
mM sodium phosphate (pH 7.4) with 0.05% DDM. (B) The spectra shown in panel A were normalized by subtracting the minimum and dividing by
the maximal ﬂuorescence intensity for the respective data set. This procedure allows a straightforward comparison of the slopes of the intensity
proﬁles for diﬀerent concentrations. The experiment was repeated ﬁve times; a representative data set is presented.
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content of ∼85% has been reported from CD measurements
and is consistent with the crystal structure.57
Aliquots from a LacY solution at a concentration of 2 μM
were taken before and after incubation at 37 °C for 48 h, and
CD spectra were recorded for each sample (Figure 4). The
spectrum of LacY as obtained from the puriﬁcation and before
incubation possesses characteristic minima at 208 and 223 nm,
indicative of a highly α-helical structure, in accord with the
LacY native fold.57 The signal intensity was reduced
signiﬁcantly after incubation of the sample at 37 °C, indicating
a loss of soluble protein. This result indicates that only soluble
protein is being detected, while the aggregated fraction crashes
out of solution and does not result in a detectable signal.
Further secondary structure determination therefore was
performed using FT-IR spectroscopy. This technique further-
more has a higher sensitivity and accuracy for resolving β-sheet
compositions.58−60 For example, whereas only changes in α-
helical content could be detected by CD spectroscopy in the
study of the secondary structure changes of opsin variants,
changes in both α-helical and β-sheet content were observed
for the same system using FT-IR spectroscopy.28 As FT-IR
requires protein concentrations higher than those obtained
from the puriﬁcation procedure, a concentrated sample was
used for this analysis. The DDM concentration of the
concentrated samples was veriﬁed via colorimetric determi-
nation of the glycoside content,49 and only small increases
[from 0.050 to 0.057% (Table S1)] were detected. Aliquots
from the LacY solution at a concentration of 16 μM were taken
before and after incubation at 37 °C for 48 h, and FT-IR
spectra were recorded for each sample (Figure 5A). The amide
I/II regions of the spectra at both time points are shown, as
well as the second-derivative spectra (Figure 5B).
The amide I band obtained for the LacY sample before
incubation has its maximum at 1653 cm−1, which is the
characteristic region for α-helical/disordered structure con-
tent.61,62 This preincubation sample, although predominantly
α-helical in nature, may contain some aggregated species
because of its high protein concentration. After 48 h, the main
peak is shifted to 1623 cm−1, where intermolecular β-sheet
structure has its characteristic maximum.61 The diﬀerences
between β-sheet structure in amyloid-like ﬁbrils compared to
that in native states of proteins is evident from FT-IR data, with
amyloid-like ﬁbrils speciﬁcally populating the amide I region
between 1610 and 1630 cm−1.63 A shift of the amide II band to
lower wavelengths further reﬂects the formation of intermo-
lecular hydrogen bonds upon incubation of the sample at 37 °C
for 48 h. Deconvolution of the FT-IR data in Figure 5A
indicates the conversion of mainly α-helical structure to a 35%
parallel β-sheet conformation after incubation at 37 °C for 48 h.
In addition, the β-turn conformation (1682 cm−1) and
antiparallel β-sheet (1695 cm−1) contents slightly increase
upon incubation of the sample, and these changes are
intimately related to formation of cross-β sheet structure.63
The FT-IR data thus indicate that the nature of the β-sheet
fraction is typical of amyloid-like ﬁbrils.63
Denaturant Resistant LacY Aggregates Have a
Fibrillar Architecture. In light of the ﬁbrillar nature of the
aggregated samples indicated by the ThT assay and FT-IR data,
we set out to obtain the corresponding ﬁber diﬀraction
patterns. The diﬀraction patterns of the LacY sample after
incubation at 37 °C for 48 h (Figure 6A) show a diﬀuse ring at
a spacing between 4.5 and 4.8 Å and a very weak reﬂection at
∼10 Å. While the observation of these reﬂections does conﬁrm
that ﬁbrillar species are present, the weakness of the signal is a
Figure 4. CD intensity decrease upon aggregation of LacY. LacY (2
μM) was incubated in 50 mM phosphate buﬀer (pH 7.4) with 0.05%
DDM at 37 °C. CD spectra were recorded before (blue) and after
(red) incubation for 48 h. The spectra were corrected for 50 mM
sodium phosphate (pH 7.4) with 0.05% DDM. A minimum of three
scans was averaged per time point. The experiment was repeated
twice; a representative data set is presented.
Figure 5. Secondary structure in LacY aggregates detected using FT-IR. (A) LacY (16 μM) was incubated in 50 mM phosphate buﬀer (pH 7.4) with
0.05−0.06% DDM at 37 °C. FT-IR spectra were recorded before (blue) and after (red) incubation for 48 h and corrected by subtracting the
spectrum of the buﬀer solution. The dotted lines indicate the peak maxima, and the arrows illustrate the peak shifts. A spectrum of LacY prior to
concentration is not shown, because the protein directly obtained from the puriﬁcation was not concentrated enough to result in a detectable
spectrum. (B) Second derivative of the spectra before (blue) and after (red) incubation for 48 h showing the appearance of peak positions in the
amide I region at 1653 and 1623 cm−1, respectively. The dotted lines indicate the main peak minima. The experiment was repeated twice; a
representative data set is presented.
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consequence of the low concentrations of ﬁbrils and/or of a
dilution eﬀect due to the presence of less ordered species. To
gain more insights into the morphology of the species present
in the LacY aggregates, transmission electron microscopy
(TEM) images were recorded for the incubated (37 °C for 48
h) LacY sample (concentration of 16−32 μM). These
measurements, although not suﬃciently accurate to reveal
quantitative parameters such as width and height, showed that
the aggregates have a ﬁbrillar morphology but are coated with
less ordered material (Figure 6C), suggesting that the low
resolution of the diﬀraction pattern is at least in part a
consequence of dilution by disordered species.
To obtain more detailed images of the ﬁbrillar species in the
samples, we set out to separate the ﬁbrillar and disordered
components of the aggregates. Amyloid-like ﬁbrils are typically
extremely stable and considerably more resistant to relatively
high concentrations of denaturant than disordered aggregates
are.64 We therefore incubated the aggregates in urea (8 M) or
guanidinium hydrochloride (3 M) for 1 h, centrifuged the
remaining insoluble material, and re-examined it via TEM. The
samples prepared in this manner show clearly the presence of
substantially more homogeneous structures (Figure 6D),
indicating that a denaturant resistant ﬁbrillar fraction can be
isolated. Following treatment of the samples in urea (8 M) or
guanidinium hydrochloride (3 M), the diﬀraction pattern was
seen to be much more highly resolved as well (Figure 6B),
showing reﬂections at 4.6 Å, characteristic of interstrand
spacing, and at 10.8 Å, corresponding to the intersheet spacing
as observed in amyloid ﬁbrils.2 The combination of these
reﬂections is consistent with the cross-β pattern indicative of a
β-sheet core structure, in which the constituent β-strands lie at
right angles to the axis of the ﬁbril. The characterized
interstrand and intersheet spacing, in combination with an
extended degree of β-sheet content, enhanced ThT ﬂuo-
rescence emission, and evidence of a ﬁbrillar morphology
indicates the ability of LacY to convert into amyloid-like ﬁbrils
in vitro.
■ CONCLUSIONS
The generality of the amyloid phenomenon has been ﬁrmly
established for cytosolic proteins through a large number of
case studies.1−8,10 By contrast, its extent remains rather unclear
for membrane proteins, for which the conversion into β-sheet-
rich aggregates has been previously suggested,16,23,28,31,32 but
only preliminary evidence of ﬁbril formation so far has been
provided.16,23,32 In this work, we have reported an extensive
characterization of aggregates of LacY as amyloid-like ﬁbrils. As
many membrane proteins have sequences and overall
architectures similar in nature to those of LacY, we anticipate
that amyloid-like structures will be described in detail for a
wider range of membrane proteins, and under a variety of
conditions, thus allowing the biological relevance of these
aggregates to be progressively deﬁned.
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